Advertisement

Editorial Board

Senior Editor

  • Donald G. Phinney, PhD, University of Florida, Scripps Biomedical Research, Gainesville, Florida, United States of America

Commissioning Editor

  • Patrick J. Hanley, PhD, Children's National Hospital, Washington, District of Columbia, United States of America

Associate Editors

  • Oscar Lee, MD, PhD, National Yang Ming Chiao Tung University - Yangming Campus, Taipei, Taiwan
  • Luis Ortiz, MD, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
  • Anna Pasetto, PhD, Karolinska Institute, Department of Laboratory Medicine, Huddinge, Sweden
  • Qasim A. Rafiq, University College London, Department of Biochemical Engineering, London, United Kingdom
  • Sowmya Viswanathan, PhD, University Health Network, Toronto, Ontario, Canada

Assistant Editor

  • Rachel Burga, PhD, Obsidian Therapeutics, Inc., Cambridge, Massachusetts, United States of America

Program Management Senior Coordinator

  • Felix Grignon, International Society for Cellular Therapy, Vancouver, British Columbia, Canada

Editorial Board

  • Alice Bertaina, MD, PhD, Stanford University, Stanford, California, United States of America
  • Jaap Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
  • Vincenzo Cardinale, MD, PhD, University of Rome La Sapienza, Roma, Italy
  • Rachele Ciccocioppo, MD, A.O.U.I. Policlinico G.B. Rossi and University of Verona, Verona, Italy
  • Nancy H. Collins, PhD, Foundation for the Accreditation of Cellular Therapy FACT, Darien, Connecticut, United States of America
  • Patrizia Comoli, PhD, Foundation IRCCS Polyclinic San Matteo Cell Factory Pediatric Hematology Oncology Unit, Pavia, Italy
  • Charles Cox Jr., MD, University of Texas Medical School, Houston, Texas, United States of America
  • Natividad Cuende, MD, MPH, PhD, Andalusian Transplant Coordination, Andalusia, Spain
  • Wanxing Cui, MD, PhD, MedStar Georgetown University Hospital, Washington, District of Columbia, United States of America
  • Colleen Delaney, MD, MSC, Nohla Therapeutics, Research & Development, Seattle, Washington, United States of America
  • Ekaterina Doubrovina, MD, PhD, Memorial Sloan-Kettering Cancer Center,, Department of Pediatrics, New York, New York, United States of America
  • Allen Eaves, MD, PhD, FRCPC, STEMCELL Technologies Inc, Vancouver, British Columbia, Canada
  • J.H.F. Falkenburg, MD, PhD, Leiden University Medical Center,, Department of Hematology, Leiden, Netherlands
  • Miguel Forte, MD, PhD, Bone Therapeutics SA, Gosselies, Belgium
  • Jacques Galipeau, MD, FRCP©, University of Wisconsin-Madison, Department of Medicine, Madison, Wisconsin, United States of America
  • Damián García-Olmo, MD, PhD, Autonomous University of Madrid, Madrid, Spain
  • Adrian Gee, PhD, Baylor College of Medicine Center for Cell and Gene Therapy,
  • Bernd Giebel, PhD, University Hospital Essen, Essen, Germany
  • Massimiliano Gnecchi, MD, PhD, University of Pavia & IRCCS Policlinico San Matteo, Pavia, Italy
  • David Gottlieb, MBBS, FRACP, FRCPA, MD, Westmead Hospital Bone Marrow Transplant & Cell Therapies Group, Westmead, New South Wales, Australia
  • Michael Gustafson, PhD, Mayo Clinic Hospital, Phoenix, Arizona, United States of America
  • Shelly Heimfeld, PhD, Fred Hutchinson Cancer Research Center Clinical Research Division, Seattle, Washington, United States of America
  • Christian Jorgensen, MD, PhD, Institute for Research in Biotherapy, Montpellier, France
  • Joanne Kurtzberg, MD, Duke University, Department of Pediatrics, Durham, North Carolina, United States of America
  • Ping Law, PhD, Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Germany
  • Bruce Levine, PhD, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
  • Rebecca Lim, PhD, Monash University, Department of Obstetrics and Gynaecology, Clayton, Australia
  • Sai-Kiang Lim, PhD, A*STAR Institute of Medical Biology, Singapore, Singapore
  • Douglas W. Losordo, MD, Caladrius Biosciences, New York, New York, United States of America
  • Mark W. Lowdell, PhD, FRCPath, FRSB, University College London Institute of Immunity and Transplantation, London, United Kingdom
  • Ivan Martin, PhD, University Hospital Basel, Basel, Switzerland
  • Robert W. Mays, PhD, Athersys, Inc.,, Department of Regenerative Medicine, Cleveland, Ohio, United States of America
  • Richard T. Maziarz, MD, Oregon Health & Science University, Adult Blood and Marrow Stem Cell Transplant Program, Portland, Oregon, United States of America
  • David H. McKenna, MD, University of Minnesota Medical School, Molecular and Cellular Therapeutics, Minneapolis, Minnesota, United States of America
  • Ian McNiece, PhD, Biocardia Inc, Miami, Florida, United States of America
  • J. Joseph Melenhorst, PhD, University of Pennsylvania, Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, United States of America
  • Jeffrey J. Molldrem, MD, University of Texas MD Anderson Cancer Center,, Department of Hematopathology, Houston, Texas, United States of America
  • George F. Muschler, MD, Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States of America
  • Robert Nordon, MB, BS, BMedSci, PhD, University of Technology Sydney, Faculty of Engineering and Information Technology, Broadway, Australia
  • Giuseppe Orlando, MD, PhD, Wake Forest University, Department of General Surgery, Winston-Salem, North Carolina, United States of America
  • Josef Priller, MD, Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité - University Medicine Berlin, Berlin, Germany
  • Claudia Rossig, MD, University Children's Hospital Muenster, Pediatric Hematology and Oncology, Muenster, Germany
  • Fermin Sanchez-Guijo, MD, PhD, Institute for Biomedical Research of Salamanca, Salamanca, Spain
  • Khalid Shah, MS, PhD, Harvard Medical School, Boston, Massachusetts, United States of America
  • Warren Sherman, MD, FACC, Cardiovascular Biotherapeutics Inc Dallas Office, Dallas, Texas, United States of America
  • Akihiro Shimosaka, PhD, Research Foundation for Community Medicine, Tokyo, Japan
  • Elizabeth J. Shpall, MD, University of Texas MD Anderson Cancer Center,, Department Stem Cell Transplantation and Cellular Therapy, Houston, Texas, United States of America
  • Sandeep Soni, MD, CRISPR Therapeutics, San Francisco, California, United States of America
  • Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC, Department of Pediatrics, Pittsburgh, Pennsylvania, United States of America
  • Satoshi Takahashi, MD, PhD, The University of Tokyo Institute of Medical Science Advanced Clinical Research Center, Tokyo, Japan
  • Torsten Tonn, MD, PhD, Dresden University Hospital, Dresden, Germany
  • Frits Van Rhee, MD, PhD, MRCP (UK), FRCPath, FACP, UAMS Myeloma Center, Little Rock, Arkansas, United States of America
  • Dominic Wall, PhD, Cell Therapies PTY Ltd, Melbourne, Victoria, Australia
  • Daniel J. Weiss, MD, PhD, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
  • Joseph C. Wu, MD, PhD, Stanford Cardiovascular Institute, Stanford, California, United States of America